Printer Friendly

WUXI BIOLOGICS INSTALLS BIOREACTOR FROM ABEC.

WuXi Biologics has selected 4,000 liter (L) Custom Single Run (CSR) disposable bioreactors from ABEC for its new commercial manufacturing facility (MFG4) in Wuxi city, Jiangsu, China. The partnership followed WuXi Biologics' successful testing and evaluation of ABEC's CSR bioreactor technology.

The 4,000L CSR is the largest single-use bioreactor size available in the industry and potentially largest-ever design in conventional disposable bioreactors, resulting in higher productivity and significantly lowering the cost of goods for cell culture-based biopharmaceuticals. The system also delivers performance comparable to stainless steel systems of that scale and can be fully customized for different products, resulting in higher cell culture productivity and faster process transfer and scale-up.

With the scale-out strategy that WuXi Biologics pioneered in the industry to use multiple disposable bioreactors for commercial manufacturing, 4,000L CSRs will enable manufacturing up to the scale of 24,000L comparable to traditional stainless steel bioreactors yet still achieving the advantages of CAPEX and timeline reduction benefited from disposables.

About WuXi Biologics

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover develop and manufacture biologics from concept to commercial manufacturing. For more information on WuXi Biologics, visit www.wuxibiologics.com.

About ABEC

Since 1974, ABEC has been a provider of integrated process solutions and services for manufacturing in the biopharmaceutical industry. A majority of the world's pharmaceutical and biotech companies are ABEC customers with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC. Whether adding capacity or improving existing facilities ABEC's turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity.

For more information, visit www.abecsingleuse.com or call 610/861-4666.

COPYRIGHT 2018 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Worldwide Biotech
Date:Apr 1, 2018
Words:295
Previous Article:SEMATHERA CLOSES $2MUS FINANCING AND LICENSING DEAL.
Next Article:LUNDBECK ACQUIRES PREXTON FOR UP TO USD 1.1 BILLION.
Topics:

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |